STAT Expert Advantage
A Look at the Breast Cancer Landscape: An Expert’s Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN’s tucatinib, & the Role of IO therapy
A Look at the Breast Cancer Landscape: An Expert’s Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN’s tucatinib, & the Role of IO therapy
In a scientific first, researchers have used CRISPR base editing to treat liver disease in fetal monkeys.
HHS released a final rule that would put abortion services under the same federal privacy protections as other health care data covered by HIPAA.
Confusion over Makena, a controversial failed preterm delivery drug, caused some pregnant women to receive an untested treatment.
The USDA order mandating H5N1 bird flu testing in dairy cows is less stringent than initially described by the agency.
Of 100 hospitals across 50 states surveyed by STAT about changes in maternal care after overturning of Roe v. Wade, only six agreed to speak.
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…
House lawmakers are aiming to pass the BIOSECURE ACT in time for it to be included in a year-end must-pass legislative package.
MultiPlan faces a class action lawsuit alleging the company and insurers “conspired to fix, suppress, and stabilize” medical payments.
Rebuilding trust in the CDC won’t be quick or easy — especially in a divisive political season — but that doesn’t make it any less…
As national awareness of mental illness rises and innovative care models emerge, many advocates now see a rare opportunity to remake mental health crisis care…